Cargando…
Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer
Hypertension is one of the main adverse effects of antiangiogenic tumor drugs and thus limits their application. The mechanism of hypertension caused by tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factors is mainly related to inhibition of the nitric oxide (NO) pathway an...
Autores principales: | Wang, Wenjuan, Li, Caie, Zhuang, Chenchen, Zhang, Haodong, Wang, Qiongying, Fan, Xin, Qi, Miaomiao, Sun, Runmin, Yu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262125/ https://www.ncbi.nlm.nih.gov/pubmed/35811723 http://dx.doi.org/10.3389/fcvm.2022.873829 |
Ejemplares similares
-
Corrigendum: Research on the mechanism and prevention of hypertension caused by apatinib through the RhoA/ROCK signaling pathway in a mouse model of gastric cancer
por: Wang, Wenjuan, et al.
Publicado: (2022) -
A narrative review on the interaction between genes and the treatment of hypertension and breast cancer
por: Wang, Wenjuan, et al.
Publicado: (2021) -
Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension
por: Li, Caie, et al.
Publicado: (2022) -
Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Zhuang, Chenchen, et al.
Publicado: (2022) -
Corrigendum: Cardiovascular risk according to body mass index in reproductive-aged women with polycystic ovary syndrome: a systematic review and meta-analysis
por: Zhuang, Chenchen, et al.
Publicado: (2023)